6-K/A

AMENDMENT 1 TO FORM 6-K

Company: XTL BIOPHARMACEUTICALS LTD
Filed: February 1, 2023
Period of Report: February 1, 2023
Accession Number: 0001213900-23-006569

View Document ↗ View on SEC.gov ↗